✦ LIBER ✦

MR in oncology drug development

✍ Scribed by Susan M. Galbraith

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 333 KB
Volume: 19
Category: Article
ISSN: 0952-3480
DOI: 10.1002/nbm.1093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

On the role of MRS in drug development

✍ Paul M. J. McSheehy 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 26 KB 👁 2 views

An excellent review of the role of MR in drug development was published this year in NMR in Biomedicine, and elegantly expounded upon at the recent 7th Conference of the ISMRM, Philadelphia. 1 The review discussed and presented detailed evidence of the current and potential contribution of NMR to th

Non-invasive MRS in new anticancer drug

Non-invasive MRS in new anticancer drug development

✍ Paul Workman; Ross J. Maxwell; John R. Griffiths 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 302 KB

Biodistribution of [125I]-labeled therap

Biodistribution of [125I]-labeled therapeutic proteins: Application in protein drug development beyond oncology

✍ Yulia Vugmeyster; David DeFranco; Pamela Szklut; Qin Wang; Xin Xu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 480 KB

Recent developments in pediatric neuro-o

Recent developments in pediatric neuro-oncology

✍ Patricia K. Duffner; Michael E. Cohen 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 783 KB

An ethical argument in support of intera

An ethical argument in support of interactions between developing world countries and pharmaceutical/biotechnology companies involved in oncology drug development

✍ Maurie Markman 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

A rational framework is proposed for the conduct of clinical cancer research in the developing world that permits all members of these societies to benefit from the efforts.

Applying pharmacogenetics in drug develo

Applying pharmacogenetics in drug development

✍ Allen D. Roses 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB